Table 2.
Test | Preoperative | 6 months | 12 months | 24 months |
---|---|---|---|---|
VAS back | ||||
Unilateral | 7.8 ± 0.8 | 2.3 ± 0.9 | 2.1 ± 1.8 | 2.1 ± 0.8 |
Bilateral | 8.1 ± 0.7 | 2.3 ± 0.7 | 2.4 ± 2.6 | 2.0 ± 1.8 |
VAS leg | ||||
Unilateral | 7.4 ± 2.8 | 2.1 ± 1.7 | 2.2 ± 1.1 | 1.9 ± 1.4 |
Bilateral | 7.1 ± 1.3 | 2.2 ± 0.9 | 2.0 ± 1.5 | 2.0 ± 1.3 |
ODI | ||||
Unilateral | 42.4 ± 16 | 20.6 ± 15.1 | 18.6 ± 5.7 | 18.8 ± 3.2 |
Bilateral | 44.3 ± 18.2 | 21.8 ± 16.4 | 19.8 ± 8.3 | 17.9 ± 7.6 |
SF-36 | ||||
PF | ||||
Unilateral | 16.7 ± 6.2 | – | 45.6 ± 9.0 | 47.2 ± 15.2 |
Bilateral | 15.8 ± 2.5 | – | 44.1 ± 11.0 | 46.1 ± 12.7 |
GH | ||||
Unilateral | 49.6 ± 13.4 | – | 58.4 ± 10.4 | 57.8 ± 16.5 |
Bilateral | 51.8 ± 8.3 | – | 57.6 ± 11.0 | 58 ± 13.3 |
MH | ||||
Unilateral | 51.3 ± 16.2 | – | 69.1 ± 15.5 | 71.5 ± 18 |
Bilateral | 50.4 ± 11.8 | – | 69.9 ± 17.4 | 72.6 ± 21.2 |
PF physical function, GH general health, MH mental health
Data presented as mean±SD. Difference significant (P < 0.01) pre- and postoperatively in both groups. Difference not significant between outcomes at 12- and 24-months follow-up for each subscale